1 / 6

U.S. Neurovascular Devices Market Share PPT

The U.S. neurovascular devices market was valued at $946 million in 2019, and is projected to reach $1,071 million by 2027, registering a CAGR of 3.8% from 2020 to 2027. <br><br>

Millerpeet
Download Presentation

U.S. Neurovascular Devices Market Share PPT

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. U.S. Neurovascular Devices Market Expected to Reach $1,071 Million by 2027 www.alliedmarketresearch.com

  2. Growth in prevalence of neurovascular diseases, rise in geriatric population across the U.S., technological developments associated with neurovascular devices, and increase in incidence of underlying disease conditions drive the U.S. Neurovascular Devices market. However, higher prices of neurovascular devices hinder the market growth. On the other hand, rise in demand for minimally invasive procedures in U.S. presents new opportunities in the coming years. Download Sample Report (Detailed COVID-19 Impact) at: https://www.alliedmarketresearch.com/request-sample/9050 www.alliedmarketresearch.com

  3. The embolization devices segment to maintain its lead position during the forecast period Based on form, the embolization devices segment accounted for more than two-fifths of the U.S. neurovascular devices market in 2019, and is estimated to maintain its lead position during the forecast period. This is attributed to increase in prevalence of neurovascular diseases, introduction of technologically advanced products, rise in R&D investment, surge in geriatric population, increase in adoption of embolization devices, and surge in launch of new and advanced neurovascular devices.  Click Here @ https://www.alliedmarketresearch.com/press-release/us-neurovascular-devices-market.html www.alliedmarketresearch.com

  4. The U.S. neurovascular devices market is segmented on the basis of product and disease pathology. Based on product, the market is divided into embolization devices, revascularization devices, thrombectomy devices, embolic protection devices, and accessory devices. The embolization devices segment contributed to more than two-fifths of the U.S. neurovascular devices market in 2019, and is estimated to maintain its lead position during the forecast period. On the other hand, the revascularization devices segment is anticipated to register the highest CAGR of 5.4% from 2020 to 2027. For Purchase Enquiry at: https://www.alliedmarketresearch.com/purchase-enquiry/9050 www.alliedmarketresearch.com

  5. Leading players • B. Braun Melsungen AG • Integer Holdings Corporation • Johnson & Johnson (Cerenovus) • Medtronic Plc. • Merit Medical Systems, Inc. • Microport Scientific Corporation • Penumbra, Inc. • SAES Getters SpA (Memry Corporation) • Stryker Corporation • Terumo Corporation (Microvention, Inc.) www.alliedmarketresearch.com

  6. Contact Us: David Correa5933 NE Win Sivers Drive#205, Portland, OR 97220United StatesUSA/Canada (Toll Free):+1-800-792-5285, +1-503-894-6022, +1-503-446-1141UK: +44-845-528-1300Hong Kong: +852-301-84916India (Pune): +91-20-66346060help@alliedmarketresearch.com www.alliedmarketresearch.com

More Related